Clinical Trial: Predicting Immunotherapy Response and Survival of Liver Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Liver)

U.S., July 12 -- ClinicalTrials.gov registry received information related to the study (NCT07059936) titled 'Predicting Immunotherapy Response and Survival of Liver Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Liver)' on July 01.

Brief Summary: CT imaging data and MR imaging data from liver cancer (hepatocellular carcinoma) patients prior to the initiation of immunotherapy (and possibly also after treatment) will be collected. The processing pipeline includes automatic tumor segmentation, radiomics feature extraction, feature selection, and construction of a classification model.

Study Start Date: July, 2025

Study Type: OBSERVATIONAL

Condition: Hepatocellular Carcinoma (HCC)

Recruitment Status: RECRUITING...